Detalles de la búsqueda
1.
Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
Clin Infect Dis
; 73(11): e4278-e4287, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146720
2.
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
N Engl J Med
; 378(24): 2346-2348, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29897849
3.
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 11(2)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36838333
4.
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.
Nat Commun
; 14(1): 1130, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854666
5.
Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.
J Virol
; 85(1): 366-77, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980510
6.
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial.
Lancet Infect Dis
; 22(1): 73-84, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34563277
7.
Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
J Virol
; 84(2): 1110-23, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19889768
8.
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.
Cell Rep Med
; 2(9): 100405, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34485950
9.
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.
Nat Commun
; 12(1): 372, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33446655
10.
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.
bioRxiv
; 2021 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564763
11.
Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance.
Vaccine
; 38(43): 6757-6765, 2020 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928588
12.
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
Vaccine
; 38(50): 7892-7896, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33139139
13.
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity.
Vaccines (Basel)
; 8(4)2020 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33066540
14.
Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA.
Vaccines (Basel)
; 8(1)2020 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32098409
15.
Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
Vaccine
; 38(5): 1258-1270, 2020 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31761502
16.
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
Science
; 370(6520): 1089-1094, 2020 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082295
17.
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
bioRxiv
; 2020 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32793901
18.
Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.
PLoS One
; 14(2): e0210749, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730999
19.
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
Vaccine
; 35(40): 5366-5372, 2017 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844407
20.
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
Virology
; 509: 90-97, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28624679